Espinosa MFVA, Padilla RÁL

Language: Spanish
References: 21
Page: 682-686
PDF size: 141.43 Kb.

ABSTRACT

A subject that has been very controvertial in the last few years in the field of the surgical pathology has been the terminology and the concept of borderline serous tumor of ovary (TSL). Recently the term of micropapillary serous carcinoma was introduced (CSMP) to define a subtype of serous tumors that are characterized for a micropapillary grow pattern and that clinically associated with a more aggressive behavior than the classic TSL since they have an increased risk of invasion, recurrence and extraovarian tumor implantation. The majority of these cases are included within the serous bordering tumors of ovary, being the truly invasive tumors even more infrequent and with more aggressive clinical course. We reported the case of a 52 years old woman with bilateral invasive micropapillary serous carcinoma of ovary.

REFERENCES

1. Hind Nassar. Carcinomas with micropapillary morphology. Clinical significance and current concepts. Adv Anat Pathol 2004;6:297-303.

2. Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol 1993;6:660-62.

3. Khayyata S, Basturk O, Adsay NV. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol 2005;18:1504-11.

4. Sakamoto K, Watanabe M, De La Cruz C, et al. Primary invasive micropapillary carcinoma of the colon. Histopathology 2005;47:479-84.

5. Kuroda N, Hamauzu T, Toi M, et al. Pulmonary adenocarcinoma with micropapillary component : an immunohistochemical study. Case report. APMIS 2005;113:550-54.

6. Ramalingam P, Middleton LP, Tamboli P, Troncoso P, Silva EG, Ayala AG. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ann Diagn Pathol 2003;7:112-19.

7. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002;26:358-64.

8. Amin MB, Ro JY, el-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder: histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994;18:1224-32.

9. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary: A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg PAthol 1996;20:1319-30.

10. Hoshi R, Tsuzuku M, Horai T, Ishikawa Y, Satoh Y. Micropapillary clusters in early-stage lung adenocarcinomas: a distinct cytologic sign of significantly poor prognosis. Cancer 2004;102:81-86.

11. Nagao T, Gaffey TA, Visscher DW, et al. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. Am J Surg Pathol 2004;28:319-26.

12. Katabuchi H, Tashiro H, Cho KR, Kurman RJ, Hedrick Ellenson L. Micropapillary serous carcinoma of the ovary: an immunohistochemical and mutational analysis of p53. Int J Gynecol Pathol 1998;17:54-60.

13. Smith Sehedev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases. Am J Surg Pathol 2003;27:25-36.

14. Piura B, Rabinovich A, Yanai-Inbar I. Micropapillary serous carcinoma of the ovary: case report and review of literature. Eur J Gynaecol Oncol 2000;21:374-76.

15. William R Hart. Borderline epithelial tumors of the ovary. Mod Pathol 2005;18:S33-S50.

16. Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111-28.

17. Sraebler A, Heselmeyer-Haddad K, Bell K, Riopel M, et al. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferativo serous tumors and serous carcinomas. Hum Pathol 2002;33:47-59.

18. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996;20:1331-45.

19. Mark EJ, Shin DH. Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Arch A Pathol Anat Histopathol 1993;422(6):445-51.

20. Butnor KJ. My approach to the diagnosis of mesothelial lesions. J Clin Pathol 2006;59(6):564-74.

21. Doglioni C, Tops AP, Laurino L, Luzzulino P, et al. Calretinin; a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-46.